COMP <GO>
STIM vs PROF // FORWARD P/E MULTIPLE
Neuronetics Inc. (NASDAQ) VS. Profound Medical Corp. (NASDAQ) • 15-METRIC TALLY: STIM 5
— PROF 3
■ METRIC PARITY
LAST: $2.38 (+5.31%) • MKT CAP: $181.3M
forward-pe
—
LAST: $5.86 (+1.38%) • MKT CAP: $214.1M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STIM VS. PROF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STIM | PROF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.50% | 70.80% | -22.30 | PROF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.25% | -17.93% | +6.68 | STIM | /fcf-yield <GO> |
| Operating Margin | -21.10% | -60.00% | +38.90 | STIM | /operating-margins <GO> |
| Net Profit Margin | -26.10% | -60.00% | +33.90 | STIM | /net-margins <GO> |
| Revenue Growth (YoY) | 99.20% | 65.30% | +33.90 | STIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.97 | -5.77 | PROF | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.9 | 47.0 | +8.90 | STIM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $181.3M | $214.1M | -$32.7M | PROF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STIM REV | PROF REV | STIM GROSS % | PROF GROSS % | STIM FCF | PROF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $149.2M | $16.1M | 48.5% | 70.8% | -$20.4M | -$38.4M |
| FY 2024 | $74.9M | $9.7M | 72.3% | 72.2% | -$31.0M | -$23.5M |
| FY 2023 | $71.3M | $5.9M | — | — | -$32.0M | -$22.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STIM // BETA —
PROF // BETA —